Filing metadata

Accession number
0001104659-18-006234
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Feb 02, 2018
Reporting period
Jan 31, 2018
Description
Insider transaction

Explore SEC Filings Hub